A safe and effective pneumonic plague vaccine would thwart the use of Y. pestis as an agent of ... Current Challenges in the Development of Vaccines for Pneumonic Plague - Medscape - Mar 01, 2008.

New bacterial mRNA vaccine technology shows promise in fighting plague, and could help address the global threat of ...

Scientists in Tel Aviv and IIBR have developed an mRNA vaccine. It combats the deadly Yersinia pestis bacterium. This bacterium causes plague. The vaccine showed 100% effectiveness in animal trials.

In a historic breakthrough for global medicine, Israeli researchers have made a ground-breaking development of the world’s ...

Anderson et al. Pneumonic Plague Pathogenesis and Immunity in Brown Norway Rats. American Journal Of Pathology , 2009; 174 (3): 910 DOI: 10.2353/ajpath.2009.071168 Cite This Page : ...

Immunisation of two rodent species with new live-attenuated mutants of Yersinia pestis CO92 induces protective long-term humoral- and cell-mediated immunity against pneumonic plague. npj Vaccines ...

Pneumonic plague, caused by the ... host immune responses and the development of both diagnostic and prophylactic tools. ... Studies have highlighted sex-based differences in vaccine efficacy, ...

Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...

Albany Medical College scientists have received a $3 million grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases to research a vaccine for plague.

The history and status of plague vaccine research is discussed. Learn why pneumonic plague vaccines should strive to prime both humoral and cellular immunity.

Pneumonic plague, caused by the bacterium Yersinia pestis, remains a subject of intense scientific scrutiny given its historical impact and potential modern threat. Research has elucidated the ...